Please login to the form below

Not currently logged in
Email:
Password:

Ferring's Inna Demidova moves to ELC

Takes up Russia and CIS role at the regulatory affairs specialist

ELC regulatory affairs Inna DemidovaThe ELC Group has appointed Inna Demidova to head up its planned Moscow office as head of regulatory affairs for Russia and the Commonwealth of Independent States (CIS).  

She moves to the Cambridge, UK-headquartered company from Ferring Pharmaceuticals, where she served as its regulatory affairs manager, and prior to that she worked at Wyeth (now part of Pfizer) and Lilly.  

ELC Group's CEO Marco Rubenstein said: “We are very pleased to welcome Inna to the ELC Group team. Her knowledge and experience of the Russian and CIS territories is extremely impressive and we look forward to rapidly expanding our presence under her expert guidance.”

  

ELC plans to open its Moscow office later this year and is eyeing further expansion in Brazil and China soon.

31st July 2014

From: Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hanover Communications

Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...

Latest intelligence

Enabling market access through outcomes-based pricing
Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines....
Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...

Infographics